Metropolitan Life Insurance Company (MetLife)’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,081
| Closed | -$56.2K | – | 720 |
|
|
2024
Q1 | $56.2K | Buy |
3,081
+464
| +18% | +$8.46K | ﹤0.01% | 1346 |
|
|
2023
Q4 | $28.6K | Hold |
2,617
| – | – | ﹤0.01% | 1750 |
|
|
2023
Q3 | $15K | Buy |
2,617
+525
| +25% | +$3.01K | ﹤0.01% | 2028 |
|
|
2023
Q2 | $16.2K | Hold |
2,092
| – | – | ﹤0.01% | 2042 |
|
|
2023
Q1 | $14K | Sell |
2,092
-712
| -25% | -$4.75K | ﹤0.01% | 2041 |
|
|
2022
Q4 | $25.1K | Hold |
2,804
| – | – | ﹤0.01% | 1886 |
|
|
2022
Q3 | $27.6K | Hold |
2,804
| – | – | ﹤0.01% | 1839 |
|
|
2022
Q2 | $22.3K | Hold |
2,804
| – | – | ﹤0.01% | 1996 |
|
|
2022
Q1 | $27.2K | Sell |
2,804
-8,328
| -75% | -$80.8K | ﹤0.01% | 1942 |
|
|
2021
Q4 | $170K | Buy |
+11,132
| New | +$170K | ﹤0.01% | 2134 |
|